Contract W58P0522C0001
Pfizer Inc · Department Of Defense · November 17, 2021
Pfizer Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on November 17, 2021 for $12.55 billion of work in pharmaceutical preparation manufacturing. Performance is in New York, NY. It was awarded under full and open competition. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2023.
Contract details
- PIID
- W58P0522C0001
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- New York, NY
- First action
- November 17, 2021
- Latest action
- March 31, 2023
Description
COVID-19 ORAL PROTEASE INHIBITOR PF-07321332
Modification timeline
-
March 31, 2023Mod P00007$0
-
March 27, 2023Mod P00006$0
-
December 13, 2022Mod P00005COVID-19 ACTION ORAL PROTEASE INHIBITOR PF-07321332 (PAXLOVID)$1.96B
-
September 7, 2022Mod P00004ORAL PROTEASE INHIBITOR PF-07321332$4.85B
-
May 12, 2022Mod P00003THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE GOVERNMENT TECHNICAL POINT OF CONTACT.$0
-
April 15, 2022Mod P00002ORAL PROTEASE INHIBITOR PF-07321332$0
-
January 7, 2022Mod P00001ORAL PROTEASE INHIBITOR PF-07321332$442.13M
-
November 17, 2021Base awardAWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332$5.29B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W58P0522C0001?
Contract W58P0522C0001 is a federal contract awarded to Pfizer Inc by Department Of Defense on November 17, 2021 for $12.55 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 7 times since the base award.
Who won contract W58P0522C0001?
Pfizer Inc won contract W58P0522C0001 from Department Of Defense.
How much is contract W58P0522C0001 worth?
Contract W58P0522C0001 has obligated $12.55 billion to date.